SEKISUI Diagnostics competitors

Zippia score 4.2

SEKISUI Diagnostics main competitors are Sysmex, CIMA Labs, and BD.

Competitor Summary. See how SEKISUI Diagnostics compares to its main competitors:

BD has the most employees (76,032).
Employees at Sysmex earn more than most of the competitors, with an average yearly salary of $89,249.

Work at SEKISUI Diagnostics?

Share your experience

SEKISUI Diagnostics vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
SEKISUI Diagnostics	1981	4.2	Framingham, MA	1	$57.0M	50
Sysmex	1968	4.8	Mundelein, IL	3	$2.0B	9,231
BD	1897	4.3	Franklin Lakes, NJ	3	$19.4B	76,032
Vericel Corp	1989	4.2	Cambridge, MA	2	$45.9M	216
Tyco Healthcare	-	3.9	Mansfield, MA	1	$790,000	25
Fresenius Kabi	1996	4.7	Lake Zurich, IL	2	$800.0M	72
BioLife Solutions	1987	4.0	Bothell, WA	3	$119.2M	54
Biomérieux	1963	4.7	Durham, NC	1	-	6,828
Lifecore	1965	4.4	Chaska, MN	1	$150.0M	255
CIMA Labs	1986	3.9	Eden Prairie, MN	1	$8.5M	120
Hyclone Laboratories Inc	1967	4.6	Logan, UT	1	$280.0M	499
W. L. Gore & Associates	1958	4.4	Newark, DE	9	$3.2B	10,500
International Technidyne Corporation	-	4.2	Piscataway, NJ	1	$9.1M	102
C.B. Fleet	1869	4.6	Lynchburg, VA	1	$200.0M	750

Rate SEKISUI Diagnostics' competitiveness in the market.

SEKISUI Diagnostics salaries vs competitors

Among SEKISUI Diagnostics competitors, employees at Sysmex earn the most with an average yearly salary of $89,249.

Compare SEKISUI Diagnostics salaries vs competitors

Company	Average salary	Hourly salary	Salary score
SEKISUI Diagnostics	$45,400	$21.83	-
Sysmex	$89,249	$42.91	-
BD	$69,049	$33.20	-
Vericel Corp	$48,460	$23.30	-
Tyco Healthcare	$44,705	$21.49	-
Fresenius Kabi	$44,731	$21.51	-

Compare SEKISUI Diagnostics job title salaries vs competitors

Company	Highest salary	Hourly salary
SEKISUI Diagnostics	$32,202	$15.48
CIMA Labs	$40,759	$19.60
BD	$40,505	$19.47
Fresenius Kabi	$39,987	$19.22
Biomérieux	$37,161	$17.87
Sysmex	$35,699	$17.16
BioLife Solutions	$32,509	$15.63
Lifecore	$32,378	$15.57
W. L. Gore & Associates	$32,308	$15.53
Vericel Corp	$32,249	$15.50
Tyco Healthcare	$32,026	$15.40
International Technidyne Corporation	$32,000	$15.38
C.B. Fleet	$31,973	$15.37
Hyclone Laboratories Inc	$31,944	$15.36

Do you work at SEKISUI Diagnostics?

Is SEKISUI Diagnostics able to compete effectively with similar companies?

SEKISUI Diagnostics jobs

SEKISUI Diagnostics demographics vs competitors

Compare gender at SEKISUI Diagnostics vs competitors

Job title	Male	Female
BioLife Solutions	40%	60%
Fresenius Kabi	59%	41%
Biomérieux	60%	40%
BD	60%	40%
W. L. Gore & Associates	62%	38%
SEKISUI Diagnostics	-	-

Male

Female

100%

75%

50%

25%

SEKISUI Diagnostics

W. L. Gore & Associates

Biomérieux

Fresenius Kabi

BioLife Solutions

25%

50%

75%

100%

Compare race at SEKISUI Diagnostics vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
BD	55%	18%	11%	12%	4%	9.9
BioLife Solutions	66%	11%	7%	11%	5%	6.4
Biomérieux	63%	11%	13%	9%	4%	9.8
Fresenius Kabi	56%	17%	11%	12%	4%	9.9
W. L. Gore & Associates	59%	16%	13%	8%	4%	9.7
Lifecore	71%	9%	9%	6%	4%	7.3

SEKISUI Diagnostics and similar companies CEOs

CEOBio

Thomas E. Polen

Michael P. Rice

BioLife Solutions

Accredited public company director. Dynamic, creative, growth and success oriented leader. Proven experience building and leading an organization from distress to profitability while increasing shareholder value 5x in 24 months.

Dominick C. Colangelo

Vericel Corp

Mr. Dominick C. Colangelo joined Promedior in December 2008 with fifteen years of pharmaceutical industry experience, including nearly a decade with Eli Lilly and Company. During his career, Mr. Colangelo has held a variety of executive positions of increasing responsibility in finance, product development, pharmaceutical operations, and corporate business development. During his tenure at Eli Lilly and Company, Mr. Colangelo held positions as an international tax attorney in the finance organization and as Director of Strategy and Business Development for Lilly’s Diabetes and Growth Disorders Product Group. He also served as a founding Managing Director of Lilly Ventures. Mr. Colangelo received a B.S.B.A. degree in Accounting from the State University of New York at Buffalo and a J.D. degree from the Duke University School of Law.

Alexandre Mérieux

Biomérieux

John Ducker

Fresenius Kabi

John Ducker is a Plant Manager at Fresenius SE Group, President/CEO at Fresenius Kabi USA, and Director at FRANCESCA'S HOLDINGS CORP. He has worked as Board Member at FRESENIUS KABI ONCOLOGY LIMITED, President/CEO at App Pharmaceuticals Inc., and Board Member at Dabur Pharma Co. Ltd. John studied at University of Cambridge.

Terri Kelly

W. L. Gore & Associates

Hisashi Ietsugu

Sysmex